Ronald S. is a Senior Director at Gilead Sciences, specializing in Global Regulatory Affairs with a focus on new product registration strategies for oncology products, including breakthrough therapies. With extensive experience in international regulatory affairs, clinical trial application requirements, and life-cycle management strategies, Ronald has worked with various notable pharmaceutical companies, including Merck Sharp & Dohme and The Janssen Pharmaceutical Companies. Ronald holds a Master of Science in Regulatory Affairs from Northeastern University and is proficient in utilizing generative AI and digital strategies to enhance regulatory intelligence and efficiency.
This person is not in any teams
This person is not in any offices